By Robert Daniel VRNM BP UK:BP. NEW YORK (MarketWatch) - Verenium Corp. /quotes/comstock/15*!vrnm/quotes/nls/vrnm (VRNM 3.90, +1.44, +58.53%) shares leaped 57% on Thursday after the Cambridge, Mass., developer of enzymes for industrial processes agreed to sell its cellulosic biofuels unit to BP Plc, /quotes/comstock/13*!bp/quotes/nls/bp (BP 37.08, +0.90, +2.49%) /quotes/comstock/23s!a:bp. (UK:BP. 401.75, +0.75, +0.19%) the U.K. integrated oil giant, for $98 million. The deal includes cellulosic biofuel facilities in Jennings, La., and San Diego. Verenium will retain its commercial enzyme business, including a technology platform for biofuels, as well as its right to develop its own lignocellulosic enzyme program. BP becomes the sole investor in Vercipia Biofuels, a 50-50 joint venture that BP and Verenium formed in February 2009. Galaxy Biofuels, which they also own 50-50, will be owned 100% by BP.
This differs with what you are saying.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM